Vital Therapies Obtains $14,041,092 New Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=b58bf6d2-52c3-47d0-a69d-f60a788447db&Preview=1 - Date
2/7/2011 - Company Name
Vital Therapies - Mailing Address
15222 Avenue of Science San Diego, CA 92128 - Company Description
Vital Therapies, Inc. (VTI) is a new company formed in 2003 to continue the development of the ELAD (Extracorporeal Liver Assist Device) System, which augments the metabolic functions of a patient’s liver, thereby enabling a bridge to transplant or liver recovery. VTI acquired the assets and business of VitaGen/Hepatix. - Website
http://www.vitaltherapies.com - Transaction Type
Debt - Transaction Amount
$14,041,092 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes were not disclosed. Convertible Promissory Note and Warrants to purchase new securities of Vital Therapies. SEC regulatory filing. - M&A Terms
- Venture Investor
Undisclosed
